Triple

T17093154
Position Surface form Disambiguated ID Type / Status
Subject Ervebo E414773 entity
Predicate hasMarketingAuthorizationHolder P26890 FINISHED
Object Merck Sharp & Dohme Corp. E106451 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Merck Sharp & Dohme Corp. | Statement: [Ervebo, hasMarketingAuthorizationHolder, Merck Sharp & Dohme Corp.]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Merck Sharp & Dohme Corp.
Context triple: [Ervebo, hasMarketingAuthorizationHolder, Merck Sharp & Dohme Corp.]
  • A. Merck & Co. chosen
    Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
  • B. Burroughs Wellcome Company
    Burroughs Wellcome Company was a pioneering American pharmaceutical firm known for its significant contributions to drug research and development in the 20th century.
  • C. Bristol Myers Squibb
    Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
  • D. Schering
    Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
  • E. GlaxoSmithKline
    GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasMarketingAuthorizationHolder
Context triple: [Ervebo, hasMarketingAuthorizationHolder, Merck Sharp & Dohme Corp.]
  • A. marketingAuthorisationHolder chosen
    Indicates the entity that holds the official authorization to market or sell a product, typically a medicinal or regulated product, in a given jurisdiction.
  • B. hasRegulatoryApproval
    Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
  • C. hasMarketingRole
    Indicates that an entity holds a position or responsibility related to marketing activities within an organization.
  • D. hasMarketingCategory
    Indicates that an entity is associated with a specific marketing category or segment used for classification or targeting.
  • E. hasMarketingClaim
    Indicates that an entity asserts or is associated with a specific marketing claim about a product, service, or brand.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886cfc8e88190b05ba466edd35591 completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e3dbfabf548190a0d37bab3d4ef2fa completed April 18, 2026, 7:31 p.m.
NED1 Entity disambiguation (via context triple) batch_6a012eec0d5c8190806e756aae848ba2 completed May 11, 2026, 1:20 a.m.
PD Predicate disambiguation batch_69e35d67b14481909fcdbdeaa5c34785 completed April 18, 2026, 10:31 a.m.
Created at: April 10, 2026, 5:35 a.m.